In a new article, a group of CNS experts at Worldwide Clinical Trials explore the relationship between genetic mutations and phenotypic characteristics of amyotrophic lateral sclerosis (ALS). This article, entitled “Patient Segmentation in ALS Studies,” appears in the Journal of Clinical Research and poses the question: Does genotypic vs. phenotypic segmentation make sense in the context of an ALS study?
Authors:
Michael Murphy, MD, PhD
Chief Medical and Scientific Officer
Tom Babic, MD, PhD
Vice President, Scientific Solutions, Neuroscience
